Class IIReported 2026-04-01

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.

Recalled by Amerisource Health Services LLC

Reason for Recall

Failed tablet specifications.

Recall Number

D-0418-2026

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2026-03-16

Reported

2026-04-01

Distribution

U.S. Nationwide

Code Info

Lot #1024852; Exp 9/30/2026

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.